Elucidation of lipoprotein particles structure by proteomic analysis
暂无分享,去创建一个
[1] B. Fagerberg,et al. Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr Published, JLR Papers in Press, November 18, 2007. , 2008, Journal of Lipid Research.
[2] K. Orino,et al. Apolipoprotein B binds ferritin by hemin-mediated binding: evidence of direct binding of apolipoprotein B and ferritin to hemin , 2008, BioMetals.
[3] D. Hommes,et al. Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease Published, JLR Papers in Press, September 22, 2007. , 2007, Journal of Lipid Research.
[4] R. Lehner,et al. Proteomic and Lipid Characterization of Apolipoprotein B-free Luminal Lipid Droplets from Mouse Liver Microsomes , 2007, Journal of Biological Chemistry.
[5] F. Rezaee,et al. SELDI-TOF mass spectrometry of High-Density Lipoprotein , 2007, Proteome Science.
[6] S. Hazen,et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype , 2007, Nature Medicine.
[7] Chii‐Ming Lee,et al. Proteomic approach to study the effects of various oxidatively modified low-density lipoprotein on regulation of protein expression in human umbilical vein endothelial cell. , 2007, Life sciences.
[8] M. Heller,et al. Compositional Protein Analysis of High Density Lipoproteins in Hypercholesterolemia by Shotgun LC-MS/MS and Probabilistic Peptide Scoring*S , 2007, Molecular & Cellular Proteomics.
[9] Subramaniam Pennathur,et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. , 2007, The Journal of clinical investigation.
[10] A. Hill,et al. Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation* , 2007, Journal of Biological Chemistry.
[11] D. Rader. Molecular regulation of HDL metabolism and function: implications for novel therapies. , 2006, The Journal of clinical investigation.
[12] A. Watson,et al. Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .
[13] H. Lindqvist,et al. Characterization of apolipoprotein M isoforms in low-density lipoprotein. , 2006, Journal of proteome research.
[14] Aldons J. Lusis,et al. A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.
[15] J. Spence. Lipoprotein(a): involved in events, but not burden of atherosclerotic disease? , 2006, Stroke.
[16] A. Tall,et al. LXR-Induced Redistribution of ABCG1 to Plasma Membrane in Macrophages Enhances Cholesterol Mass Efflux to HDL , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[17] Albert K Groen,et al. Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. , 2006, The Journal of clinical investigation.
[18] J. Kastelein,et al. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[19] G. Hortin,et al. Diverse range of small peptides associated with high-density lipoprotein. , 2006, Biochemical and biophysical research communications.
[20] T. Huh,et al. Proteome analysis of human monocytic THP‐1 cells primed with oxidized low‐density lipoproteins , 2006, Proteomics.
[21] D. Giugliano,et al. Inflammation warms up the metabolic syndrome. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[22] Michael Kinter,et al. Proteomic and Transcriptomic Analyses of Macrophages with an Increased Resistance to Oxidized Low Density Lipoprotein (oxLDL)-induced Cytotoxicity Generated by Chronic Exposure to oxLDL* , 2005, Molecular & Cellular Proteomics.
[23] B. Fagerberg,et al. A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500161-JLR200 , 2005, Journal of Lipid Research.
[24] M. Mann,et al. Exponentially Modified Protein Abundance Index (emPAI) for Estimation of Absolute Protein Amount in Proteomics by the Number of Sequenced Peptides per Protein*S , 2005, Molecular & Cellular Proteomics.
[25] R. Brasseur,et al. Apolipoprotein L-I Promotes Trypanosome Lysis by Forming Pores in Lysosomal Membranes , 2005, Science.
[26] D. Corella,et al. SINGLE NUCLEOTIDE POLYMORPHISMS THAT INFLUENCE LIPID METABOLISM: Interaction with Dietary Factors. , 2005, Annual review of nutrition.
[27] D. Rader,et al. New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport , 2005, Circulation research.
[28] N. Davidson,et al. CD36 deficiency impairs intestinal lipid secretion and clearance of chylomicrons from the blood. , 2005, The Journal of clinical investigation.
[29] M. Hayden,et al. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. , 2005, The Journal of clinical investigation.
[30] Per Leanderson,et al. Lipoproteomics II: Mapping of proteins in high‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.
[31] P. Delafontaine,et al. Protein chip‐based microarray profiling of oxidized low density lipoprotein‐treated cells , 2005, Proteomics.
[32] Xianlin Han,et al. Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes , 2005, Expert review of proteomics.
[33] E. Niki,et al. Proteomic characterization of oxidative dysfunction in human umbilical vein endothelial cells (HUVEC) induced by exposure to oxidized LDL , 2005, Free radical research.
[34] D. Ng. Insight into the Role of LCAT from Mouse Models , 2004, Reviews in Endocrine and Metabolic Disorders.
[35] B. Behrendt,et al. Scavenger Receptor Class B Type I Mediates the Selective Uptake of High-Density Lipoprotein–Associated Cholesteryl Ester by the Liver in Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[36] G. Gibbons,et al. Synthesis and function of hepatic very-low-density lipoprotein. , 2004, Biochemical Society transactions.
[37] S. Chuck,et al. Ferritins Can Regulate the Secretion of Apolipoprotein B* , 2003, Journal of Biological Chemistry.
[38] R. Macfarlane,et al. Analysis of high-density lipoprotein apolipoproteins recovered from specific immobilized pH gradient gel pI domains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2003, Analytical chemistry.
[39] G. Assmann,et al. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders. , 2003, Atherosclerosis.
[40] R. Brasseur,et al. Apolipoprotein L-I is the trypanosome lytic factor of human serum , 2003, Nature.
[41] Xavier Collet,et al. Ectopic β-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis , 2003, Nature.
[42] M. Hussain,et al. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.R200014-JLR200 , 2003, Journal of Lipid Research.
[43] D. Ramji,et al. Lipoprotein lipase: structure, function, regulation, and role in disease , 2002, Journal of Molecular Medicine.
[44] P. Bondarenko,et al. MALDI- and ESI-MS of the HDL apolipoproteins; new isoforms of apoA-I, II , 2002 .
[45] J. Vance,et al. Microsomal Triacylglycerol Transfer Protein Is Required for Lumenal Accretion of Triacylglycerol Not Associated with ApoB, as Well as for ApoB Lipidation* , 2002, The Journal of Biological Chemistry.
[46] L. Martinez,et al. Hepatic lipase: structure/function relationship, synthesis, and regulation. , 2002, Journal of lipid research.
[47] S. Chuck,et al. A Proteomic Approach Identifies Proteins in Hepatocytes That Bind Nascent Apolipoprotein B* , 2002, The Journal of Biological Chemistry.
[48] A. Tall,et al. High Density Lipoprotein (HDL) Particle Uptake Mediated by Scavenger Receptor Class B Type 1 Results in Selective Sorting of HDL Cholesterol from Protein and Polarized Cholesterol Secretion* , 2001, The Journal of Biological Chemistry.
[49] G. Chisolm,et al. Oxidized LDL-induced injury and apoptosis in atherosclerosis. Potential roles for oxysterols. , 2001, Trends in cardiovascular medicine.
[50] M. Pfeffer,et al. VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial , 2000, Circulation.
[51] C. Gabel,et al. High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[52] C. Packard,et al. Apolipoprotein B overproduction by the perfused liver of the St. Thomas' mixed hyperlipidemic (SMHL) rabbit. , 1999, Journal of lipid research.
[53] P. Bondarenko,et al. Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. , 1999, Journal of lipid research.
[54] H. Herscovitz,et al. Multiple Molecular Chaperones Interact with Apolipoprotein B during Its Maturation , 1998, The Journal of Biological Chemistry.
[55] A. Rigotti,et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] E. Edelman,et al. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels , 1997, Nature.
[57] G. Assmann,et al. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. , 1997, Journal of lipid research.
[58] J. Breslow,et al. Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibility. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[59] Ann Smith,et al. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. , 1996, Biochemistry.
[60] R. Pease,et al. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion , 1996, Current opinion in lipidology.
[61] S. Cockcroft. ARF-regulated phospholipase D: a potential role in membrane traffic. , 1996, Chemistry and physics of lipids.
[62] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[63] D. Rader,et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia , 1993, Nature.
[64] H. Hobbs,et al. Molecular definition of the extreme size polymorphism in apolipoprotein(a). , 1993, Human molecular genetics.
[65] N. Maeda,et al. Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[66] D. Russell. Cholesterol biosynthesis and metabolism , 1992, Cardiovascular Drugs and Therapy.
[67] A. Tall,et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. , 1991, The Journal of biological chemistry.
[68] A. Tall,et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.
[69] G. Bondjers,et al. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. , 1990, Journal of lipid research.
[70] A. Tall,et al. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins , 1989, Nature.
[71] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[72] D. Steinberg,et al. Macrophage Oxidation of Low Density Lipoprotein Generates a Modified Form Recognized by the Scavenger Receptor , 1986, Arteriosclerosis.
[73] C. S. Wang,et al. Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.
[74] F. Field,et al. beta-sitosterol: esterification by intestinal acylcoenzyme A: cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. , 1983, Journal of lipid research.
[75] D. Steinberg,et al. Enhanced Macrophage Degradation of Biologically Modified Low Density Lipoprotein , 1983, Arteriosclerosis.
[76] K. Berg,et al. The apoE polymorphism studied by two‐dimensional, high‐resolution gel electrophoresis of serum , 1981, Clinical genetics.
[77] J. Breslow,et al. Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification. , 1981, Biochemistry.
[78] P. Kinnunen,et al. Lipolysis of ApoC-II deficient very low density lipoproteins: enhancement of lipoprotein lipase action by synthetic fragments of apoC-II. , 1979, Biochemical and biophysical research communications.
[79] J. Řeřábek. Two-dimensional immunoelectrophrophoretic pattern of low- and very-low-density lipoproteins, with particular reference to Fredrickson's type III. , 1977, Clinical chemistry.
[80] A. L. Latner,et al. The separation of plasma lipoproteins using gel electrofocusing and polyacrylamide gradient gel electrophoresis. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[81] V. Shore,et al. Heterogeneity in protein subunits of human serum high-density lipoproteins. , 1968, Biochemistry.
[82] P. Alaupovic,et al. STUDIES OF THE COMPOSITION AND STRUCTURE OF SERUM LIPOPROTEINS: ISOLATION, PURIFICATION, AND CHARACTERIZATION OF VERY LOW DENSITY LIPOPROTEINS OF HUMAN SERUM. , 1965, Biochemistry.
[83] G. Fimia,et al. Proteomic analysis of human very low‐density lipoprotein by two‐dimensional gel electrophoresis and MALDI‐TOF/TOF , 2007, Proteomics.
[84] Farhad Rezaee,et al. Proteomic analysis of high‐density lipoprotein , 2006, Proteomics.
[85] P. Leanderson,et al. Lipoproteomics I: Mapping of proteins in low‐density lipoprotein using two‐dimensional gel electrophoresis and mass spectrometry , 2005, Proteomics.
[86] J. Berliner,et al. A role for oxidized phospholipids in atherosclerosis. , 2005, The New England journal of medicine.
[87] M. Krieger. Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.
[88] G. Bondjers,et al. Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation. , 1994, Journal of lipid research.
[89] D. Rader,et al. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease. , 1994, The Journal of clinical investigation.
[90] A. Damião,et al. [Chylomicron metabolism]. , 1989, Revista do Hospital das Clinicas.
[91] D. Russell,et al. Receptor-mediated endocytosis: concepts emerging from the LDL receptor system. , 1985, Annual review of cell biology.
[92] W. H. Heaton,et al. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. , 1982, Arteriosclerosis.